Deal of the Day — limited-time pharmacy picks!
Docefect 20mg Injection

Docefect 20mg Injection

Prescription requiredRx Required

Salt Composition: Docetaxel Injection IP

Expiry Date: 01/2028

Special offer

Buy at $20.58

$20.58

Inclusive of all taxes

▼

1 Vial(s) Of 1ml

About The Product

Breast Cancer, Lung Cancer, Prostate Cancer, Stomach Cancer, Head Cancer, Neck Cancer


Description

Docefect 20mg Injection is an anti-neoplastic chemical based medication that is a part of chemotherapy. It treats multiple cancers including Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, Stomach Cancer as well as Head and Neck Cancer.

Docemaps 20mg Injection contains Docetaxel that inhibits cell division of cancer cell. As a result, cancer cell growth stops and eventually gets eradicated from the body.

Common Side Effects

• Headache
• Dizziness
• Pain or Swelling at the injection site
• Loss of Appetite
• Mouth Sores
• Muscle Pain
• Constipation
• Taste Change
• Difficulty in Swelling
• Breathlessness
• Edema
• Low Platelet Count
• Severe Infection
• Liver Function Impairment
• Allergic Reactions
• Nerve Damage

Dosage And Administration

  • The exact dosage of Docefect 20mg Injection depends on the type of cancer being treated, its stage, patient's weight as well as overall health of the body.
  • The standard dosage for breast cancer as well as other solid tumors is 60-100mg/m2.
  • The prescribed dosage by the doctor is administered intravenously (into veins) by a doctor or experienced nurse.
  • Do not try to Self Administer the injection.

Mechanism Of Action

Docemaps 20mg Injection contains Docetaxel that mainly disrupt the microtubule structure in cancer cells that further inhibits cell division of cancer cell.

As a result, cancer cell growth stops and eventually gets eradicated from the body.

Faqs

The ambient temperature to store Docefect 20mg Injection is 2-8 degree celcius.

References

• Baker, S. D., Sparreboom, A., & Verweij, J.

(2006). Clinical pharmacokinetics of docetaxel: recent developments.

Clinical pharmacokinetics, 45(3), 235-252. • Cortes, J. E., & Pazdur, R.

(1995). Docetaxel.

Journal of Clinical Oncology, 13(10), 2643-2655. • Baker, J., Ajani, J., Scotté, F., Winther, D., Martin, M., Aapro, M. S., & von Minckwitz, G.

(2009). Docetaxel-related side effects and their management.

European journal of oncology nursing, 13(1), 49-59. • Lyseng-Williamson, K. A., & Fenton, C.

(2005). Docetaxel: a review of its use in metastatic breast cancer.

Drugs, 65(17), 2513-2531.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026